Stock UniverseDerived research view · source repositories remain read-only

Perspective Therapeutics, Inc. (CATX)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Speculative
Selection Score
27.96
Global Rank
2332
Market Cap
615.14M
Latest Close
3.03
RS Composite
-21.57% · G#2723

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-20.68%
3M
-39.03%
6M
37.10%
1Y
-3.19%
3Y
-42.83%
5Y
-62.13%
10Y
-68.11%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.79M · 30-day average: 1.46M · Max drawdown over stored range: -93.08%

Research Snapshot

Relative Strength vs SPX

RS Composite-21.57%
20D RS-16.47%
60D RS-50.93%
120D RS5.23%
Global RS Rank2723 · 18.84% percentile
Watch+Speculative RS Rank1667 · 20.51% percentile
Group ScopeWatch+Speculative
Primary RS Rank110 · 22.54% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank112 / 246
Primary Percentile54.88
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CATX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue10.05301.4341.4540.884
Revenue Growth (YoY)3.853%2900%-73.518%1.395%-39.202%
Gross Profit5.1210-18.909-37.975
Operating Income-3.437-6.419-40.941-66.797
Free Cash Flow-3.218-7.976-37.985-72.708-95.233
Free Cash Flow Per Share-0.31-0.562-1.419-1.129-1.2901927844688603
EPS (Diluted) GAAP-0.32646-0.512159-1.737707-1.230562
EPS Growth
EPS Non-GAAP
Gross Margin50.94%2900%2900%2900%100%
Operating Margin-34.189%2900%-2855.021%-4594.017%-12846.6063%
Profit Margin-33.721%2900%-3243.236%-5452.476%-11665.2715%
Free Cash Flow Margin-32.01%2900%-2648.884%-5000.55%-10772.9638%
Shares Outstanding (Diluted)10.384114.198726.76464.42573.813
Shares Change (YoY)53.609%36.735%88.384%140.715%14.572%

SEC Quarterly Fundamentals

No processed quarterly rows for CATX.